JB Bio 2 ApS: Financial statements 2022
CVR: 41041722
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
JB Bio 2 ApS (CVR 41041722) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -4,632 and a net result of DKK -4,725 compared with DKK -27,367 the year before. Equity in the 2022 report amounted to DKK 2,533. The solvency ratio was 20.8%.
- Gross Profit
- DKK -4,632
- Profit/Loss
- DKK -4,725
- Equity
- DKK 2,533
- Total Assets
- DKK 12,158
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -5 t. | -5 t. | 3 t. | 0 |
| 2021 | - | -7 t. | -27 t. | 7 t. | - |
| 2020 | - | -9 t. | -9 t. | 35 t. | - |
Official annual report
Keep an eye on JB Bio 2 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
JB Bio 2 ApS has published its annual report for 2021. Gross profit came to DKK -7,250, and the net result was DKK -27,367.
About JB Bio 2 ApS
JB Bio 2 ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jannick Dyrløv Bendtsen. The company is owned by Jannick Dyrløv Bendtsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -58,700 and a net result of DKK -7,715,676 compared with DKK 27,177,154 the year before. Equity in the 2025 report amounted to DKK 17,959,153.